Imperial Petroleum Inc.
DE ˙ DB ˙ MHY3894J1872
42,12 € ↓ -0,56 (-1,32%)
2019-07-30
DEL PRIS
SecurityDE:AR2 / Imperial Petroleum Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership173,444 shares
Latest Disclosed Value $ 742,340
Jane Street Group, Llc ownership in AR2 / Imperial Petroleum Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 173,444 shares of Imperial Petroleum Inc. (DE:AR2) valued at $742,340 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 253,978 shares of Imperial Petroleum Inc.. This represents a change in shares of -31.71% during the quarter. The current value of the position is $7,306,328 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (AR2) in the form of stock options. The firm currently holds call options representing 43,100 of underlying shares valued at $184,468 USD and put options representing 17,500 of underlying shares valued at $74,900 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:AR2 / Imperial Petroleum Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F IMPERIAL PETE COM NEW Y3894J187 173,444 -80,534 -31.71 742 -19.26 0.0000
2026-02-12 2025-12-31 13F IMPERIAL PETE COM NEW Y3894J187 253,978 8,954 3.65 919 -21.52 0.0001
2025-11-14 2025-09-30 13F IMPERIAL PETE COM NEW Y3894J187 245,024 245,024 1,171 0.0002
2024-05-16 2024-03-31 13F IMPERIAL PETE COM NEW Y3894J187 0 -24,983 -100.00 0 -100.00
2024-02-15 2023-12-31 13F IMPERIAL PETE COM NEW Y3894J187 24,983 24,983 66 0.0000
2019-11-14 2019-09-30 13F ARRAY BIOPHARMA COM 04269X105 0 -54,982 -100.00 0 -100.00
2019-08-15 2019-06-30 13F ARRAY BIOPHARMA COM 04269X105 54,982 -60,675 -52.46 2,547 -9.68 0.0045
2019-05-16 2019-03-31 13F ARRAY BIOPHARMA COM 04269X105 115,657 115,657 2,820 0.0046
2019-02-14 2018-12-31 13F ARRAY BIOPHARMA COM 04269X105 0 -22,059 -100.00 0 -100.00
2018-11-14 2018-09-30 13F ARRAY BIOPHARMA COM 04269X105 22,059 10,329 88.06 335 70.05 0.0007
2018-08-15 2018-06-30 13F ARRAY BIOPHARMA COM 04269X105 11,730 -10,851 -48.05 197 -46.61 0.0005
2018-05-15 2018-03-31 13F ARRAY BIOPHARMA COM 04269X105 22,581 -47,225 -67.65 369 -58.72 0.0010
2018-02-15 2017-12-31 13F ARRAY BIOPHARMA COM 04269X105 69,806 9,609 15.96 894 20.81 0.0026
2017-11-14 2017-09-30 13F ARRAY BIOPHARMA COM 04269X105 60,197 34,612 135.28 740 245.79 0.0024
2017-08-14 2017-06-30 13F ARRAY BIOPHARMA COM 04269X105 25,585 25,585 214 0.0007
2017-05-15 2017-03-31 13F ARRAY BIOPHARMA COM 04269X105 0 -27,396 -100.00 0 -100.00
2017-02-15 2016-12-31 13F ARRAY BIOPHARMA COM 04269X105 27,396 -36,257 -56.96 241 -43.95 0.0011
2016-11-14 2016-09-30 13F ARRAY BIOPHARMA COM 04269X105 63,653 63,653 0.00 430 0.0021
2016-08-15 2016-06-30 13F ARRAY BIOPHARMA COM 04269X105 0 -11,302 -100.00 0 -100.00
2016-05-17 2016-03-31 13F ARRAY BIOPHARMA COM 04269X105 11,302 11,302 0.00 33 0.0002
2016-02-16 2015-12-31 13F ARRAY BIOPHARMA COM 04269X105 0 -35,627 -100.00 0 -100.00
2015-11-16 2015-09-30 13F ARRAY BIOPHARMA COM 04269X105 35,627 35,627 0.00 162 0.0010
2015-02-17 2014-12-31 13F ARRAY BIOPHARMA COM 04269X105 0 -38,219 -100.00 0 -100.00
2014-11-14 2014-09-30 13F ARRAY BIOPHARMA COM 04269X105 38,219 7,940 26.22 136 -1.45 0.0014
2014-08-14 2014-06-30 13F ARRAY BIOPHARMA COM 04269X105 30,279 30,279 138 0.0018
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F IMPERIAL PETE COM NEW Call 43,100 150.58 184 196.77 n/a n/a n/a
2026-02-12 2025-12-31 13F IMPERIAL PETE COM NEW Call 17,200 -18.48 62 -38.00 n/a n/a n/a
2025-11-14 2025-09-30 13F IMPERIAL PETE COM NEW Call 21,100 -67.13 101 -49.24 n/a n/a n/a
2025-08-14 2025-06-30 13F IMPERIAL PETE COM NEW Call 64,200 174.36 198 245.61 n/a n/a n/a
2025-05-19 2025-03-31 13F/A IMPERIAL PETE COM NEW Call 23,400 57 n/a n/a n/a
2025-05-14 2025-03-31 13F IMPERIAL PETE COM NEW Call 23,400 57 n/a n/a n/a
2019-11-14 2019-09-30 13F ARRAY BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-15 2019-06-30 13F ARRAY BIOPHARMA COM Call 33,500 -20.80 1,552 50.53 n/a n/a n/a
2019-05-16 2019-03-31 13F ARRAY BIOPHARMA COM Call 42,300 1,031 n/a n/a n/a
2019-02-14 2018-12-31 13F ARRAY BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-14 2018-09-30 13F ARRAY BIOPHARMA COM Call 11,200 -84.00 170 -85.53 n/a n/a n/a
2018-08-15 2018-06-30 13F ARRAY BIOPHARMA COM Call 70,000 498.29 1,175 515.18 n/a n/a n/a
2018-05-15 2018-03-31 13F ARRAY BIOPHARMA COM Call 11,700 -93.55 191 -91.78 n/a n/a n/a
2018-02-15 2017-12-31 13F ARRAY BIOPHARMA COM Call 181,500 744.19 2,323 779.92 n/a n/a n/a
2017-11-14 2017-09-30 13F ARRAY BIOPHARMA COM Call 21,500 264 n/a n/a n/a
2017-08-14 2017-06-30 13F ARRAY BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-05-15 2017-03-31 13F ARRAY BIOPHARMA COM Call 16,700 -77.12 149 -69.78 n/a n/a n/a
2016-11-14 2016-09-30 13F ARRAY BIOPHARMA COM Call 73,000 493 n/a n/a n/a
2016-05-17 2016-03-31 13F ARRAY BIOPHARMA COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F ARRAY BIOPHARMA COM Call 12,800 54 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F IMPERIAL PETE COM NEW Put 17,500 75 n/a n/a n/a
2019-08-14 2019-06-30 13F ARRAY BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-16 2019-03-31 13F ARRAY BIOPHARMA COM Put 29,300 715 n/a n/a n/a
2018-11-14 2018-09-30 13F ARRAY BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-08-15 2018-06-30 13F ARRAY BIOPHARMA COM Put 26,000 100.00 436 105.66 n/a n/a n/a
2018-05-15 2018-03-31 13F ARRAY BIOPHARMA COM Put 13,000 212 n/a n/a n/a
2018-02-15 2017-12-31 13F ARRAY BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F ARRAY BIOPHARMA COM Put 28,700 173.33 353 397.18 n/a n/a n/a
2016-11-14 2016-09-30 13F ARRAY BIOPHARMA COM Put 10,500 71 n/a n/a n/a
2016-05-17 2016-03-31 13F ARRAY BIOPHARMA COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F ARRAY BIOPHARMA COM Put 10,000 42 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.